Updates are available Correction dated 2026-05-08
Click to view Correction: https://doi.org/10.1186/s40168-026-02424-7
-
Authors
Granato, Alessandra
Renwick, Simone
Yau, Christopher
Kong, Tiffany
Daigneault, Michelle C.
Knip, Mikael
,
Allen-Vercoe, Emma
Danska, Jayne S.
- License Information
-
More Information
Article History
Received: 15 August 2023
Accepted: 12 November 2024
First Online: 5 December 2024
Change Date: 22 April 2026
Change Type: Update
Change Details: The original article has been updated: Figures 2 and 3 were updated.
Change Date: 8 May 2026
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1186/s40168-026-02424-7
Declarations
:
: Selected fecal samples from DIABIMMUNE sample database were shipped to the Allen-Vercoe lab under the University of Guelph REB no. 17–06-006 for chemostat culture.
: Not applicable.
: EAV is a co-founder of Nubyota, a company focused on the human gut microbiome. AG, SR, CY, TK, MCD, MK, and JSD declare that they have no competing interests.
